FILTER
FILTERED INTERVIEW RESULTS
David Cory
CEO, EIGER BIOPHARMACEUTICALS
Founded in 2008, Eiger BioPharmaceuticals is a late-stage biopharmaceutical company focused on developing and commercializing targeted therapies for rare diseases.
Barbara Weber
CEO, TANGO THERAPEUTICS
Tango Therapeutics is targeting unaddressed disease mechanisms in cancer to develop transformational new drugs for patients.
Michael Bigham & Evan Loh
PARATEK PHARMACEUTICALS
Paratek focuses on drugs that target infectious disease and other difficult-to-treat conditions.
Richard Peters
PRESIDENT AND CEO, MERRIMACK PHARMACEUTICALS
Merrimack Pharmaceuticals is focused on cancer treatment through a deeper understanding of cancer pathways and biological markers.
Ankit Mahadevia & Cristina Larkin
CEO & CHIEF COMMERCIAL OFFICER, SPERO THERAPEUTICS
Spero Therapeutics is developing new antimicrobial drugs to substitute those that have become ineffectual as they meeting resistance.
Travis McCready
PRESIDENT & CEO, MASSACHUSETTS LIFE SCIENCES CENTER
The Massachusetts Life Sciences Center has spent a billion dollars to ensure the best possible environment for the life sciences industry.
Robert K. Coughlin
PRESIDENT & CEO, MASSACHUSETTS BIOTECHNOLOGY COUNCIL
Founded in 1985, MassBio’s mission is to advance Massachusetts’ leadership in life sciences to grow the industry.
Thomas Wicks
CHIEF STRATEGY OFFICER, TRIALSCOPE
TrialScope helps trial sponsors to comply with disclosure regulations and internal transparency policies for jurisdictions across the world and is developing a program to provide easily intelligible interpretations of trial results for the patients that are involved in trials.
Valarie Higgins
PRESIDENT & MANAGING DIRECTOR, ALMAC CLINICAL TECHNOLOGIES
Almac Clinical Technologies designs and deploys complex software that helps trial sponsors automate complex decisions that occur in clinical trials.
Josh Grauso
SALES MANAGER, UL CONSUMER & RETAIL SERVICES
UL helps companies meet safety and compliance standards and regulations across the pharma industry.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Africa Energy 2024 - Pre-release
The pre-release edition of Africa Energy 2024 comprises analysis based on over 80 interviews with ministers and leading executives from IOCs, NOCs, independents, associations, investors and service providers, to provide an in-depth and holistic view of sub-Saharan Africa’s ever-evolving energy sector.
The pre-release edition of Africa Energy 2024 comprises analysis based on over 80 interviews with ministers and leading executives from IOCs, NOCs, independents, associations, investors and service providers, to provide an in-depth and holistic view of sub-Saharan Africa’s ever-evolving energy sector.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
